Hyperrab 300 unit/ML vial 5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA0UF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,006
Award facts
- Contract value 100% obligated
- $26,006.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $26,006.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML Vial 5ML, a rabies immunoglobulin product used for post-exposure prophylaxis treatment. The non-set-aside contract was awarded on December 22, 2025, with an ultimate completion date of January 14, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026, serving as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated substantial federal procurement capabilities through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency. The company supplies a comprehensive range of pharmaceutical products and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The SPE2DX contract encompasses critical medical supplies including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains, positioning AmerisourceBergen as a key vendor in the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FA0UF?
SPE2DR26FA0UF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FA0UF worth?
The government has obligated $26,006 on SPE2DR26FA0UF.
Is contract SPE2DR26FA0UF an order under another contract?
Yes. SPE2DR26FA0UF is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA0UF competed?
The extent of competition for SPE2DR26FA0UF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award